Home › Research › Clinical safety
Delusions and hallucinations in Alzheimer's disease: prevalence and clinical correlates
Bassiony MM, Steinberg MS, Warren A, Rosenblatt A, Baker AS, Lyketsos CG.. International journal of geriatric psychiatry, 2000-02-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Objectives The purpose of this study was to examine the frequency of delusions and hallucinations in patients with Alzheimer's disease (AD) and to investigate factors associated with each or the combination of the two. Design This was a cross-sectional, case-control study. Setting Neuropsychiatry and Memory Group, The Johns Hopkins University, USA. Participants Three hundred and forty-two community-residing patients with probable AD according to NINCDS/ADRDA criteria were included in the study. Measures Patients were assessed clinically for the presence of psychotic symptoms using the DSM-IV glossary definitions. The patients were also rated on standardized measures of cognitive impairment, depression, extrapyramidal symptoms, functional impairment and general health. Results Seventy-five (22%) AD patients had delusions only, nine (3%) had hallucinations only and 30 (9%) had both delusions and hallucinations. Hallucinations were associated with less education, African-American race, more severe dementia, longer duration of illness, falls and use of anxiolytics. Delusions were associated with older age, depression, aggression, poor general health and use of antihypertensives. Patients with both delusions and hallucinations were similar to the patients with delusions only. Conclusions This study confirms the high prevalence of psychotic symptoms in AD patients encountered in clinical practice and suggests that individual psychotic symptoms have different associations.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Bassiony, M. M., Steinberg, M. S., Warren, A., Rosenblatt, A., Baker, A. S., & Lyketsos, C. G. (2000). Delusions and hallucinations in Alzheimer's disease: prevalence and clinical correlates. International journal of geriatric psychiatry. https://doi.org/10.1002/(sici)1099-1166(200002)15:2<99::aid-gps82>3.0.co;2-5
Vancouver
Bassiony MM, Steinberg MS, Warren A, Rosenblatt A, Baker AS, Lyketsos CG. Delusions and hallucinations in Alzheimer's disease: prevalence and clinical correlates. International journal of geriatric psychiatry. 2000. doi:10.1002/(sici)1099-1166(200002)15:2<99::aid-gps82>3.0.co;2-5. PMID: 10679840.
BibTeX
@article{bassiony2000-10679840,
author = {Bassiony, M. M. and Steinberg, M. S. and Warren, A. and Rosenblatt, A. and Baker, A. S. and Lyketsos, C. G.},
title = {{Delusions and hallucinations in Alzheimer's disease: prevalence and clinical correlates}},
journal = {International journal of geriatric psychiatry},
year = {2000},
doi = {10.1002/(sici)1099-1166(200002)15:2<99::aid-gps82>3.0.co;2-5},
pmid = {10679840},
url = {https://doi.org/10.1002/(sici)1099-1166(200002)15:2<99::aid-gps82>3.0.co;2-5}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Objectives The purpose of this study was to examine the frequency of delusions and hallucinations in patients with Alzheimer's disease (AD) and to investigate factors associated with each or the combination of the two.
- Results Seventy-five (22%) AD patients had delusions only, nine (3%) had hallucinations only and 30 (9%) had both delusions and hallucinations.
- Hallucinations were associated with less education, African-American race, more severe dementia, longer duration of illness, falls and use of anxiolytics.
- Delusions were associated with older age, depression, aggression, poor general health and use of antihypertensives.
- Conclusions This study confirms the high prevalence of psychotic symptoms in AD patients encountered in clinical practice and suggests that individual psychotic symptoms have different associations.
Study details
- Study designcase-control study
- Evidence strengthModerate
How this study scored 50/100
Published in a peer-reviewed journal, and it is a case-control study. Scored zero for sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 29 of the 58 points we could judge it on, which is 50 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (International journal of geriatric psychiatry) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 6 / 12 | A case-control study |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2000 — older than 20 years, still counted |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 10679840) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 29 / 58 | Scored on 11 of 20 parts. We have no data for the rest, so they are left out: 29 of the 58 points we could judge it on is 50 out of 100. |
| Total | 50 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1002/(sici)1099-1166(200002)15:2<99::aid-gps82>3.0.co;2-5
- PubMed: 10679840
- Original source →
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Clinical safety from nearby years
Also in Clinical safety
96 studies in the library are filed under Clinical safety with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Clinical safety hub.